The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors of early mortality in children and adolescents enrolled in oncology trials with a dose-finding part in the era of targeted and immune therapies: An Innovative Therapies for Children with Cancer (ITCC) study.
 
Fernando Carceller
Stock and Other Ownership Interests - GlaxoSmithKline
 
Harm van Tinteren
No Relationships to Disclose
 
Alicia Castañeda
No Relationships to Disclose
 
Aurore Surun
No Relationships to Disclose
 
Lynley V. Marshall
Honoraria - Bayer; Eisai; Merck
Consulting or Advisory Role - Illumina
 
Arnauld Verschuur
No Relationships to Disclose
 
Luca Bergamaschi
No Relationships to Disclose
 
Marta Cortes
No Relationships to Disclose
 
Antony Ceraulo
No Relationships to Disclose
 
Gerard Millen
No Relationships to Disclose
 
Quentin Campbell-Hewson
No Relationships to Disclose
 
Antonio Juan-Ribelles
No Relationships to Disclose
 
Jasper van der Lugt
No Relationships to Disclose
 
Loredana Amoroso
No Relationships to Disclose
 
Nicoletta Bertorello
Consulting or Advisory Role - Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Amgen
 
Darren R. Hargrave
Honoraria - Alexion Pharmaceuticals; AstraZeneca/MedImmune; Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Novartis; Roche/Genentech
Speakers' Bureau - Alexion Pharmaceuticals
Research Funding - AstraZeneca
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Boehringer Ingelheim; Novartis; Roche/Genentech
Other Relationship - Abbvie; AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Day One Therapeutics; Epizyme; Novartis
 
Francois Doz
Consulting or Advisory Role - Ipsen (Inst); Novartis (Inst); Roche/Genentech (Inst); SERVIER (Inst)
Research Funding - ONXEO (Inst)
Travel, Accommodations, Expenses - Bayer
 
Gilles Vassal
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Hutchison MediPharma; Lilly; Novartis; Pfizer; Pyramid Biosciences; Roche/Genentech
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche
 
Birgit Geoerger
Consulting or Advisory Role - AZD; Boehringer Ingelheim; Novartis; Roche/Genentech
 
Lucas Moreno
Honoraria - Bayer (Inst); EUSA Pharma (Inst)
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Norgine (Inst); Novartis (Inst); Shionogi (Inst)
Patents, Royalties, Other Intellectual Property - Member of SIOPEN Executive Committee, SIOPEN receives royalties for the sales of dinutuximab beta (Inst)
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc (Inst)